Latest filing published 18 Dec 2013 for OMNICELL, INC., €45k.
No signal scores available.
Michael D. Stevenson discloses dealings in 2 companies, chiefly MTS Medication Technologies, Inc /DE/ and Omnicell, Inc. Between 1 April 2005 and 16 December 2013, the trades on record add up to 37 filings.
The open-market record consists of 26 sales worth €519k, with no purchase. No amount is published for 1 filing, which the totals therefore leave out. Besides market trades, the filings include 3 share grants and 7 option exercises.
On 18 December 2013 came the latest disclosure, a share grant for €45k in Omnicell, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 37 declarations